Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Necrotizing Enterocolitis Market Expected To Become By 2029 Compared With Its 2025 Level?
The necrotizing enterocolitis market size has demonstrated strong growth in recent years. It is expected to expand from $4.83 billion in 2024 to $5.14 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.5%. The expansion witnessed in the past can be ascribed to the increasing prevalence of necrotizing enterocolitis, a rise in global populations, growing per capita income, increased government funding, and a higher number of premature births.
The necrotizing enterocolitis market is projected to experience substantial expansion over the coming years, anticipated to reach a valuation of $6.56 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.3%. This growth during the forecast period can be attributed to the escalating costs associated with healthcare, the incidence and prevalence of ulcerative colitis (UC), an increase in gastrointestinal diseases, a growing number of geriatric and obese individuals, and the expanding geriatric population overall. Key trends shaping the market over the forecast period include advancements in biomarker research for early NEC detection, developments in non-invasive testing methods, the adoption of advanced monitoring systems, improvements in surgical techniques, and the development of targeted therapies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22068&type=smp
What Are The Drivers Pushing New Developments In The Necrotizing Enterocolitis Market?
A rise in premature birth instances is anticipated to drive the expansion of the necrotizing enterocolitis market in the future. Premature births, also known as preterm births, refer to the delivery of a baby before 37 weeks of gestation, in contrast to the typical 40-week pregnancy term. The growing number of premature births stems from maternal health conditions such as high blood pressure, diabetes, and infections, which heighten the risk of preterm labor, and lifestyle factors, including smoking, drug use, and poor nutrition, contribute to a greater probability of these births. An increase in premature births results in a higher incidence of necrotizing enterocolitis (NEC) because premature infants possess underdeveloped gastrointestinal systems, making them more vulnerable to inflammation and infection. For example, data from January 2024, provided by the US government agency Centers for Disease Control and Prevention, indicates that premature births constitute 8.67% of all annual births in the United States. Consequently, the escalating occurrences of premature births are fueling the growth of the necrotizing enterocolitis market.
What Are The Segment Types Shaping The Necrotizing Enterocolitis Market?
The necrotizing enterocolitismarket covered in this report is segmented –
1) By Treatment: Total Parenteral Nutrition (TPN); Gastrointestinal Decompression; Antimicrobial Therapy; Antifungal Treatment; Paracentesis; Other Treatments
2) By Diagnosis: Laboratory Tests; Imaging Techniques
3) By Stage: Stage I (Suspected Necrotizing Enterocolitis); Stage II (Definite Necrotizing Enterocolitis); Stage III (Advanced Necrotizing Enterocolitis)
4) By Distribution Channel: Direct Tender; Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End-User: Hospitals; Neonatal Intensive Care Units (NICUs); Specialty Clinics
Subsegments:
1) By Total Parenteral Nutrition (TPN): Standard TPN Formulations; Customized Or Individualized TPN Solutions; Lipid Emulsions for TPN; Protein And Amino Acid Supplements In TPN; Micronutrient And Electrolyte-Enhanced TPN
2) By Gastrointestinal Decompression: Nasogastric Tube (NG Tube) Decompression; Orogastric Tube Decompression; Surgical Gastrostomy for Decompression; Non-Surgical Decompression Techniques
3) By Antimicrobial Therapy: Broad-Spectrum Antibiotics; Gram-Positive Coverage Antibiotics; Gram-Negative Coverage Antibiotics; Combination Antibiotic Therapy; Prophylactic Antibiotic Strategies For High-Risk Neonates
4) By Antifungal Treatment: Systemic Antifungal Therapy; Prophylactic Antifungal Therapy For Preterm Infants; Combination Antifungal And Antibiotic Therapy For Severe NEC
5) By Paracentesis: Diagnostic Paracentesis; Therapeutic Paracentesis; Guided Paracentesis using Ultrasound Or Radiological Techniques
6) By Other Treatments: Probiotics And Prebiotics for NEC Prevention; Surgical Interventions; Stem Cell Therapy And Regenerative Medicine Approaches; Immunomodulatory Therapies; Supportive Care
What Long-Term Trends Will Shape The Future Growth Of The Necrotizing Enterocolitis Industry?
Leading companies in the necrotizing enterocolitis market are concentrating on developing advanced product solutions, such as cell-free sterile biologic solutions, to fulfill the urgent demand for effective treatments and improve outcomes for premature infants. A cell-free sterile biologic solution is defined as a purified, sterile liquid that contains bioactive molecules, including proteins, growth factors, and cytokines, derived from cultured cells but without any intact cells, specifically designed to promote healing and reduce inflammation. For example, in December 2023, Noveome Biotherapeutics, Inc., a US-based biopharmaceutical company, received authorization from the U.S. Food and Drug Administration (FDA) to proceed with its Phase 1-2 clinical trial for ST266, a new biologic intended for treating necrotizing enterocolitis (NEC) in premature infants. This signifies an important landmark, as ST266 is projected to be the first significant therapeutic breakthrough for NEC in over 30 years, addressing a critical medical necessity given the disease’s high morbidity and mortality rates among susceptible populations.
Who Are The Top Performing Companies In The Necrotizing Enterocolitis Market In Recent Years?
Major companies operating in the necrotizing enterocolitis market are Abbott Laboratories, Astellas Pharma Inc., Mayo Foundation for Medical Education and Research, Cleveland Clinic, Boston Children’s Hospital, Hollister Incorporated, UPMC Children’s Hospital of Pittsburgh, Prolacta Bioscience Inc., Evolve BioSystems, Sigma-Tau Pharmaceuticals, Mead Johnson & Company LLC, Liminal BioSciences Inc., Noveome Biotherapeutics Inc., Infant Bacterial Therapeutics, Prometic Life Sciences Inc., Nexilico, Siolta Therapeutics, ProThera Biologics Inc., Plakous Therapeutics Inc., Chosen Diagnostics Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/necrotizing-enterocolitis-global-market-report
Which Region Shows The Highest Potential For Future Expansion In The Necrotizing Enterocolitis Market?
North America was the largest region in the necrotizing enterocolitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the necrotizing enterocolitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Necrotizing Enterocolitis Market Report:
https://www.thebusinessresearchcompany.com/customise?id=22068&type=smp
Browse Through More Reports Similar to the Global Necrotizing Enterocolitis Market 2025, By The Business Research Company
Gastrointestinal Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report
Gastrointestinal Bleeding Treatment Devices Global Market Report 2025
Gastrointestinal Endoscopy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastrointestinal-endoscopy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model